Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative
暂无分享,去创建一个
A. Silman | D. Symmons | M. Dougados | D. Felson | F. Wolfe | G. Hawker | T. Pincus | P. Tak | P. Emery | T. Huizinga | L. Moreland | V. Bykerk | J. Vencovský | G. Burmester | P. Mease | A. Kavanaugh | C. Bingham | J. Smolen | B. Combe | T. Kvien | D. Aletaha | T. Neogi | J. Funovits | N. Birnbaum | Marc-David Cohen | K. Costenbader | G. Ferraccioli | J. Hazes | K. Hobbs | J. Kay | T. Laing | H. Ménard | R. Naden | E. Stanisławska-Biernat | K. Upchurch | M. Cohen | Í. Vencovský | H. Ménard | J. Vencovský | J. Vencovský | Julia Funovits
[1] W. Grassi,et al. Tips and tricks to recognize microcrystalline arthritis. , 2012, Rheumatology.
[2] A. Kerr,et al. Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. , 2012, The New Zealand medical journal.
[3] Shuai Leng,et al. Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation. , 2011, Radiology.
[4] Hyon K. Choi,et al. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.
[5] A. Silman,et al. UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .
[6] A. Silman,et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. , 2010, Arthritis and rheumatism.
[7] A. Silman,et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I , 2010, Annals of the rheumatic diseases.
[8] I. Peláez-Ballestas,et al. Diagnosis of Chronic Gout: Evaluating the American College of Rheumatology Proposal, European League Against Rheumatism Recommendations, and Clinical Judgment , 2010, The Journal of Rheumatology.
[9] C. van Weel,et al. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. , 2010, Archives of internal medicine.
[10] K. Liao,et al. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. , 2009, Arthritis and rheumatism.
[11] D. M. van der Heijde,et al. The prognostic value of baseline erosions in undifferentiated arthritis , 2009, Arthritis research & therapy.
[12] H. Schumacher,et al. Clinical Diagnostic Criteria for Gout: Comparsion With the Gold Standard of Synovial Fluid Crystal Analysis , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[13] D. M. van der Heijde,et al. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature , 2008, Annals of the rheumatic diseases.
[14] Andrew Filer,et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. , 2008, Arthritis and rheumatism.
[15] P. Hansen,et al. A new method for scoring additive multi‐attribute value models using pairwise rankings of alternatives , 2008 .
[16] L. Annemans,et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005 , 2007, Annals of the rheumatic diseases.
[17] Michael H Weisman,et al. New therapies for treatment of rheumatoid arthritis , 2007, The Lancet.
[18] J. Singh,et al. Classification criteria in rheumatic diseases: a review of methodologic properties. , 2007, Arthritis and rheumatism.
[19] M. Weinblatt,et al. Optimal use of methotrexate: the advantages of tight control , 2007, Annals of the rheumatic diseases.
[20] C. Allaart,et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. , 2007, Arthritis and rheumatism.
[21] A. Silman,et al. Reconciling subject differences in recruitment to clinical trials and clinical practice. , 2005, The Journal of rheumatology.
[22] Wei Chen,et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. , 2005, Arthritis and rheumatism.
[23] E. Massarotti,et al. Rheumatoid Arthritis: An Overview of New and Emerging Therapies , 2005, Journal of clinical pharmacology.
[24] W. Bilker,et al. Gout epidemiology: results from the UK General Practice Research Database, 1990–1999 , 2005, Annals of the rheumatic diseases.
[25] B. Dijkmans,et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.
[26] Göran Hallmans,et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[27] T. Pincus,et al. Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. , 2003, Clinical and experimental rheumatology.
[28] G. Firestein. Evolving concepts of rheumatoid arthritis , 2003, Nature.
[29] A. Silman,et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. , 2003, Arthritis and rheumatism.
[30] M. Uffmann,et al. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease. , 2002, The Journal of rheumatology.
[31] B. Pal,et al. How is Gout Managed in Primary Care? A Review of Current Practice and Proposed Guidelines , 2000, Clinical Rheumatology.
[32] F. Wolfe,et al. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. , 1998, Arthritis and rheumatism.
[33] P. Jones,et al. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. , 1998, The Journal of rheumatology.
[34] K. Bohndorf,et al. Diagnostic radiography in rheumatoid arthritis: benefits and limitations. , 1996, Bailliere's clinical rheumatology.
[35] A. van der Heide,et al. The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs , 1996, Annals of Internal Medicine.
[36] F. Wolfe,et al. The natural history of rheumatoid arthritis. , 1996, The Journal of rheumatology. Supplement.
[37] D. Heijde. Joint erosions and patients with early rheumatoid arthritis , 1995 .
[38] D. van der Heijde,et al. Joint erosions and patients with early rheumatoid arthritis. , 1995, British journal of rheumatology.
[39] K. Aho,et al. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. , 1993, The Journal of rheumatology.
[40] H. Isomäki. Long-term outcome of rheumatoid arthritis. , 1992, Scandinavian journal of rheumatology. Supplement.
[41] T. Tuomi,et al. Rheumatoid factors antedating clinical rheumatoid arthritis. , 1991, The Journal of rheumatology.
[42] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[43] D. Symmons,et al. LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS , 1987, The Lancet.
[44] J. Fries,et al. Survival, prognosis, and causes of death in rheumatoid arthritis. , 1986, Arthritis and rheumatism.
[45] T. Pincus,et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. , 1984, Arthritis and rheumatism.
[46] D. Mccarty,et al. Preliminary criteria for the classification of the acute arthritis of primary gout. , 1977, Arthritis and rheumatism.
[47] J. S. Lawrence,et al. The Epidemiology of Chronic Rheumatism , 1964 .